Pharmacovigilance promotes the safe and effective use of medicines and thereby optimizes the treatment quality. However, lack of awareness among community pharmacists towards pharmacovigilance decreases the proportion of adverse drug reactions reported and impairs the signal detection process. Hence this study was designed to assess and promote the awareness and attitude of community pharmacists towards pharmacovigilance. This educational interventional study was carried out with 102 community pharmacists across Chennai. A pre-validated three domain-containing questionnaire, 20 items was used to assess the knowledge, attitude and practice before and after the educational intervention. Knowledge, attitude and practices of community pharmacists towards pharmacovigilance was signi icantly increased after the educational intervention (P<0.05, 95%CI). Median difference in an overall score of knowledge and practice was observed to be 4 and 4.5, respectively.
INTRODUCTION
Pharmacovigilance involves the sequential activities of detecting, assessing, understanding, managing, and preventing of adverse drug reactions (ADRs) (Campbell et al., 2015) . Pharmacovigilance aims to promote the safe and effective use of medicines, thereby increasing the quality of treatment each patient receives (Sahu et al., 2014) . Minimizing the risk of adverse events through pharmacovigilance also tend to decrease the direct and indirect costs spent towards pharmacotherapy (Qing-Ping et al., 2014) . Treatment decisions are always made taking risk-bene it ratio into consideration. Therefore, pharmacovigilance paves path for developing systemic strategies for ADR risk strati ication (Al-Wora i et al., 2017) . The unequivocal role of pharmacists in ADR reporting is a crucial element for effective pharmacovigilance (Toklu and Mensah, 2016) . Community pharmacists usually spent adequate time with patients and possessed relevant clinical expertise to understand the onset of ADRs (Tsuyuki et al., 2018) . Moreover, the quality of ADR reports sent to global pharmacovigilance process can be enhanced upon screening by community pharmacists (Baniasadi et al., 2014) .
However, ADRs are often under-reported by health care professionals, including community pharmacists, due to the lack of awareness about signi icance, reporting modalities and regular work schedule (Almandil, 2016) . Underreported ADRs have detrimental effects on the signal generation process and compromise the quality of pharmacotherapy. In order to ease and facilitate the spontaneous reporting the Pharmacovigilance Program of India (PvPI), has put forth several initiatives such as the launch of mobile applications for ADR reporting (Kalaiselvan et al., 2016) . Health care professionals, especially community pharmacists, need to be educated regarding the signi icance of pharmacovigilance and reporting modalities to strengthen the signal generation process (Yu and Lee, 2017) . Pharmacists trained in pharmacovigilance would educate fellow pharmacist and colleagues on the signi icance of ADR reporting and reporting strategies and thereby promote pharmacovigilance (Olsson, 2008) . Hence, it is crucial to assess the awareness and attitude of community pharmacists towards pharmacovigilance and provide adequate training to promote their active involvement in ADR reporting as they are health care professionals readily accessible to patients.
METHODOLOGY

Study Site and Approval
This study was conducted for a period of 5 months in 95 community pharmacies across Chennai. The protocol was reviewed and approved by the Institutional Ethics Committee of VELS Institute of Science, Technology and Advanced Studies before study commencement Consent from the authorities of the community pharmacies was obtained prior to administration of questionnaires to CPs. (Ref No.: VISTAS-SPS/IEC/II/2018/09).
Subject Recruitment and Con identiality
Community pharmacists in pre-identi ied study sites were requested participation. The study protocol was thoroughly explained to the participants by the investigator. Community pharmacists were enrolled into the study only on the provision of written informed consent. All data were documented in specially designed case report forms, and access was restricted to the investigator to ensure non-violation of subject rights and con identiality.
Study Design
Non-Randomized Experimental.
Sample Size
A sample size of 102 community pharmacists was 
Inclusion Criterion
CPs in identi ied study sites with the minimum quali ication for the practice of pharmacy profession as prescribed by the Pharmacy Council of India (PCI) have an active registration with any of the state pharmacy councils and willing to provide written informed consent.
Exclusion Criterion
Unquali ied individuals dispensing medications
in community pharmacies.
2. Pharmacists who are not working in a community setup.
3. CPs who are unwilling to provide a written informed consent. 
Statistical Methods
Descriptive summary of demographic and clinical variables is presented either as mean ± SD or as median (minimum and maximum). Choice of the descriptive and inferential statistical method was based on distribution normality as determined through normal probability plot and Shapiro-Wilk test. Statistical analyses were performed using International Business Machines -Statistical Package for the Social Sciences (IBM -SPSS) 20.0 and R statistical package.
RESULTS AND DISCUSSION
Age, gender, educational quali ication, years of experience and type of employment wise distribution of Community Pharmacists are shown inTable 1. Pre and post-intervention knowledge of Community Pharmacists towards Adverse Drug Reactions and Pharmacovigilance are shown in Table 2 . Effect of educational intervention on Knowledge of Community Pharmacists is illustrated in Figure 1 . Pre and post-intervention attitude of Community Pharmacists towards Adverse Drug Reactions and its reporting are shown inTable 3. Pre and post-intervention Practice of Community Pharmacists towards Adverse Drug Reactions and its reporting are shown in Table 4 . Effect of educational intervention on the Practice of Community Pharmacists is illustrated in Figure 2 . Training and education of community pharmacists on the aspects of pharmacovigilance would promote ADR reporting and enhance the quality of ADR reports sent to global monitoring centers (Li et al., 2018) .
Hence, in this interventional study, we assessed the knowledge, attitude and practice of community pharmacists and provided them adequate education on the importance of ADR reporting, the role of the PvPI and different modalities of reporting adverse drug reactions using a pre-validated questionnaire (Anbalagan and Shanmugasundaram, 2019) . It was observed that the overall knowledge of community pharmacists enhanced after the educational intervention. Though 96.1% community pharmacists were aware of the fact that no drug molecule is free of adverse effects, they were unaware about their signi icant role in pharmacovigilance process. Lack of awareness of community pharmacists towards pharmacovigilance is of signi icant concern as it leads to under-reporting of ADRs (Said and Hussain, 2017) . The attitude of community pharmacists towards ADR reporting was relatively less before the educational intervention. Twenty-two per cent of community pharmacists expressed a negative opinion regarding their participation in pharmacovigilance while 65.7% of pharmacists expressed neutral attitude and only 12.7% felt that they should be involved in ADR reporting. The initial negative and neutral attitude of community pharmacists towards ADR reporting could be due to hesitation to take up the additional workload, fear of legal issues and/or monetary loss. This was evident in item A 2 regarding their interest in attending pharmacovigilance, where 87.3% of phar- macists expressed a negative opinion. Pharmacists stated indirect monetary loss due to refraining from work by attending the training program as a reason. Similar results have been reported in previous studies where pharmacists have initially expressed a negative opinion to attend pharmacovigilance training programs (Syed et al., 2018) . However, there was a signi icant improvement in pharmacist attitude towards pharmacovigilance with 90.2% feeling that they should be involved in pharmacovigilance. The initial response of pharmacist towards practice was also found to be low. Initially, 1.96% of pharmacists stated that they have reported previously reported adverse events which increased only to 22.54% after an educational intervention. This relatively low increase in ADR reporting is because of the less time interval between the sampling points (1 Month). Almost 60% of pharmacists reported that they haven't observed any adverse event in the last month. Hence future studies with longer time intervals between sampling points are crucial to determine the effect of educational interventions on the attitude towards pharmacovigilance. However, the other practices of the community pharmacist in the prevention of ADR, such as counselling care has signi icantly improved after the intervention. The results of our studies are on par with previous studies that have previously attempted to promote the knowledge, attitude and practice of community pharmacists towards pharmacovigilance (Ahmad et al., 2013; Alsaleh et al., 2017) .
CONCLUSIONS
We have assessed the awareness and attitude of community pharmacists toward pharmacovigilance using a pre-validated questionnaire. Knowledge, attitude and practice of community pharmacists towards ADR reporting was also increased through educational intervention. Promotion of awareness and attitude of community pharmacist toward pharmacovigilance would strengthen the signal generation process and aid in enhancing the quality of treatment. Nationwide mass educational programs to promote the awareness and attitude of community pharmacists towards pharmacovigilance are required to train community pharmacist across the country on aspects of pharmacovigilance.
